Klein & Scannapiego, MD., PA
Klein & Scannapiego, MD., PA was paid $6.05M by Medicaid between Jan 2018 and Nov 2024, across 54 billing codes. Its largest line is 92014, Ophthalmological services: medical examination and evaluation, comprehensive, established patient — 23% of everything it billed.
ELIZABETH, NJ 07202
Next to other Eyewear Supplier providers in New Jersey
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,716 | $994K | |
| 2019 | 33,742 | $914K | |
| 2020 | 24,590 | $616K | |
| 2021 | 26,400 | $721K | |
| 2022 | 37,429 | $874K | |
| 2023 | 43,872 | $1.10M | |
| 2024incomplete | 32,538 | $833K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 23% | 31,485 | 30,103 | $1.38M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 11% | 10,800 | 10,434 | $684K |
| 92015 | Determination of refractive state | 8.2% | 36,434 | 35,019 | $494K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.5% | 9,519 | 9,174 | $454K |
| 92250 | 6.8% | 21,217 | 19,783 | $414K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 6.4% | 14,048 | 12,766 | $384K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 5.2% | 1,542 | 1,236 | $318K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.1% | 3,435 | 3,376 | $249K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 3.1% | 5,354 | 4,311 | $188K |
| 99243 | 2.8% | 1,813 | 1,812 | $169K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 2.8% | 11,243 | 11,222 | $167K |
| 92226 | 1.8% | 8,206 | 4,660 | $108K |
42 more codes
| 92273 | 1.7% | 3,471 | $103K | |
| 92083 | 1.6% | 5,697 | $98K | |
| 92020 | 1.4% | 10,234 | $87K | |
| 92225 | 1.4% | 4,578 | $86K | |
| V2020 | Frames, purchases | 1.1% | 5,340 | $68K |
| 92134 | <1% | 5,105 | $60K | |
| 92201 | <1% | 6,502 | $60K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | <1% | 4,013 | $49K |
| 92133 | <1% | 4,314 | $46K | |
| 92286 | <1% | 4,987 | $45K | |
| 66762 | <1% | 294 | $41K | |
| 92136 | <1% | 1,955 | $34K | |
| 92025 | <1% | 2,804 | $33K | |
| 76512 | <1% | 1,924 | $32K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 453 | $28K |
| 92285 | <1% | 4,617 | $27K | |
| V2200 | Sphere, bifocal, plano to plus or minus 4.00d, per lens | <1% | 979 | $21K |
| 65855 | <1% | 247 | $21K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 552 | $17K |
| 65426 | <1% | 62 | $16K | |
| 92275 | <1% | 330 | $15K | |
| 92060 | <1% | 648 | $14K | |
| 92202 | <1% | 2,634 | $10K | |
| 66761 | <1% | 90 | $8K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 198 | $7K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 57 | $7K |
| 66821 | <1% | 51 | $5K | |
| 76514 | <1% | 675 | $4K | |
| 92341 | <1% | 426 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 47 | $2K |
| 68761 | <1% | 17 | $707.31 | |
| 86328 | <1% | 33 | $699.20 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $590.00 |
| J7999 | Compounded drug, not otherwise classified | <1% | 222 | $455.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 55 | $442.27 |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 514 | $126.00 |
| 99000 | <1% | 28 | $15.00 | |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 0% | 26 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 21 | $0.00 |
| V2750 | Anti-reflective coating, per lens | 0% | 939 | $0.00 |
| V2203 | Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 0% | 26 | $0.00 |
| V2025 | Deluxe frame | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Paterson Eye Associates | Elmwood Park, NJ | $1.43M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.